Search results
6444 items matching your search terms.
- Growth hormone-induced insulin resistance and its relationship to lipid availability in the rat
- DIABETES 45 (4) :415-21, 1996
- Vitamin D receptors and osteoporosis
- Current Opinion in Orthopaedics 7 :35-39, 1996
- Insulin response in bulimia nervosa as a marker of nutritional depletion
- Int J Eat Disord 20 (3) :307-13, 1996
- Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer
- CLINICAL CANCER RESEARCH 2 (6) :923-8, 1996
- Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines
- INTERNATIONAL JOURNAL OF CANCER 68 (4) :485-92, 1996
- Sex steroid regulation of growth hormone secretion and action
- Hormone Research in Paediatrics 45 (1-2) :67-73, 1996
- Disorders of bone and calcium homeostasis
- Therapeutic Guidelines: Endocrinology :333-375, 1996
- Sensory cells of the chick cochlea express synaptophysin
- NEUROSCIENCE LETTERS 216 (2) :89-92, 1996
- Calcium and vitamin D therapy in corticosteroid bone loss: what is the evidence
- JOURNAL OF RHEUMATOLOGY 23 (6) :963-4, 1996
- The association between myxedematous ascites and extreme elevation of serum tumor markers
- JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 81 (11) :4175, 1996
- Characterization of two forms of protein kinase C alpha, with different substrate specificities, from skeletal muscle
- BIOCHEMICAL JOURNAL 320 ( Pt 1) :207-14, 1996
- Conservative management of fibroadenoma of the breast
- BRITISH JOURNAL OF SURGERY 83 (7) :992-3, 1996
- Vitamin D receptor gene variants: implications for therapy
- CURRENT OPINION IN GENETICS & DEVELOPMENT 6 (3) :361-5, 1996
- Osteoporosis
- MEDICAL JOURNAL OF AUSTRALIA 165 (6) :332-6, 1996
- Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis
- CLINICAL CANCER RESEARCH 2 (7) :1177-84, 1996
- Alendronate (Fosamax): clinical utility in metabolic bone disease
- EXPERT OPINION ON INVESTIGATIONAL DRUGS 5 :1691-1705, 1996